Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Pain and nausea are known causes of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Pain and nausea are common during treatment for malignancy. This study aimed to investigate associations of analgesics and antiemetics, as surrogates for pain and nausea respectively, with hyponatremia among patients with malignancy.
This is a retrospective cohort study among patients with malignancy at our university hospital from 2018 to 2023. We utilized mixed-effects logistic regression analyses to examine the associations of acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and antiemetics with hyponatremia (Na ≤130 mmol/L). To account for the different strengths of analgesics, we created a “Pain score” defined as the sum of the following points: 1 point for acetaminophen, 2 points for NSAIDs, and 3 points for opioids. The association between “Pain score” and hyponatremia was also examined.
We enrolled 5506 patients. Median age was 68 (57-75) years, and median eGFR was 70.2 (57.5-82.9) mL/min/1.73㎡. Of these, 1313 (23.9%) developed hyponatremia at least once during the study period. Acetaminophen, NSAIDs, and opioids were all significantly associated with hyponatremia {Odds Ratio [OR] 1.27 [95% confidence interval (CI) 1.16-1.39], OR 1.41 [95% CI 1.27-1.55], and OR 1.33 [95% CI 1.15-1.55], respectively}. However, antiemetics were not associated with hyponatremia [OR 1.06 (95% CI 0.89-1.26)]. A higher “Pain score” was progressively associated with hyponatremia: 1 point [OR 1.38 (95% CI 1.21-1.57)], 2 points [OR 1.53 (95% CI 1.32-1.77)], 3 points [OR 1.75 (95% CI 1.54-2.00)], 4 points [OR 1.83 (95% CI 1.45-2.32)], 5 points [OR 2.06 (95% CI 1.51-2.80)], and 6 points [OR 2.53 (95% CI 2.06-3.11)] as compared to 0 points (P for trend <0.01). The associations were stronger among patients with impaired renal function (eGFR <60 mL/min/1.73㎡; p for interaction = 0.03), but not among renin-angiotensin system (RAS) inhibitor users (p for interaction = 0.37).
Analgesic use was associated with hyponatremia, while antiemetic use was not. Furthermore, stronger analgesic use, reflecting severe pain, was associated with an increased risk of hyponatremia. In contrast, antiemetic use is not a good surrogate for the severity of nausea, because these drugs are also used for nausea prevention. This may explain the lack of association between antiemetic use and hyponatremia. Proper pain control may help reduce the risk of hyponatremia and improve the quality of life, especially among patients with malignancy and kidney disease.
